{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:38:04Z","timestamp":1769827084769,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaad.2025.03.056","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T17:49:00Z","timestamp":1743097740000},"page":"423-428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current therapeutic options for adult patients with urticarial vasculitis: A scoping review"],"prefix":"10.1016","volume":"93","author":[{"given":"Anne-Sophie","family":"Groleau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Mereniuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Makhzoum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3810\/pgm.2001.02.861","article-title":"Acute and chronic urticaria. Challenges and considerations for primary care physicians","volume":"109","author":"Krishnaswamy","year":"2001","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.2008.03693.x","article-title":"An approach to the patient with urticaria","volume":"153","author":"Deacock","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2025.03.056_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100107","article-title":"Management of urticarial vasculitis: a worldwide physician perspective","volume":"13","author":"Kolkhir","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"1","key":"10.1016\/j.jaad.2025.03.056_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MD.0000000000000013","article-title":"Urticarial vasculitis in northern Spain: clinical study of 21 cases","volume":"93","author":"Loricera","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.jaad.2025.03.056_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ad.2012.12.004","article-title":"Urticarial vasculitis: a retrospective study of 15 cases","volume":"104","author":"Moreno-Su\u00e1rez","year":"2013","journal-title":"Actas Dermosifiliogr"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/039463200601900203","article-title":"Diagnostic and therapeutic iter in chronic urticaria patients","volume":"19","author":"Tosoni","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2230.2008.02891.x","article-title":"A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients","volume":"34","author":"Tosoni","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2025.03.056_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1346-8138.2010.00881.x","article-title":"Clinical efficacy of reserpine as \"add-on therapy\" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis","volume":"37","author":"Demitsu","year":"2010","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.revmed.2017.03.005","article-title":"Les vascularites urticariennes hypocompl\u00e9ment\u00e9miques [Hypocomplementemic urticarial vasculitis]","volume":"39","author":"Jachiet","year":"2018","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.jaad.2025.03.056_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4103\/idoj.IDOJ_248_18","article-title":"Vasculitis: a checklist to approach and treatment update for dermatologists","volume":"10","author":"Sangolli","year":"2019","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1385\/CRIAI:23:2:201","article-title":"Urticarial vasculitis","volume":"23","author":"Venzor","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2025.03.056_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2009.09538.x","article-title":"Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria","volume":"162","author":"Perez","year":"2010","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.03.056_bib1","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1136\/annrheumdis-2019-215605","article-title":"Dramatic but suspensive effect of interleukin-1 inhibitors for persistent urticarial vasculitis: a French multicentre retrospective study","volume":"78","author":"Bettuzzi","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2025.03.056_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/ced.12320","article-title":"Improvement in quality of life impairment followed by relapse with 6-monthly periodic administration of omalizumab for severe treatment-refractory chronic urticaria and urticarial vasculitis","volume":"39","author":"Kai","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.03.056_bib3","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.jaip.2020.02.024","article-title":"Response of omalizumab in normocomplementemic urticarial vasculitis","volume":"8","author":"Chen","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.jaad.2025.03.056_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijwd.2021.01.021","article-title":"Urticarial vasculitis","volume":"7","author":"Gu","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaci.2018.09.007","article-title":"Treatment of urticarial vasculitis: a systematic review","volume":"143","author":"Kolkhir","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2025.03.056_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaci.2013.04.008","article-title":"Efficacy and safety of canakinumab in urticarial vasculitis: an open-label study","volume":"132","author":"Krause","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2025.03.056_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.38956","article-title":"The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients","volume":"67","author":"Jachiet","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.03.056_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12882-022-02689-8","article-title":"Biopsy-proven kidney involvement in hypocomplementemic urticarial vasculitis","volume":"23","author":"Corthier","year":"2022","journal-title":"BMC Nephrol"},{"issue":"5","key":"10.1016\/j.jaad.2025.03.056_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clindermatol.2006.07.007","article-title":"Cutaneous vasculitis: diagnosis and management","volume":"24","author":"Carlson","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2025.03.056_bib22","series-title":"StatPearls [internet]","first-page":"1","article-title":"Corticosteroid adverse effects","author":"Yasir","year":"2025"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225005250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T20:38:02Z","timestamp":1758659882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225005250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0190962225005250"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.03.056","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current therapeutic options for adult patients with urticarial vasculitis: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.03.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}